Skip to main content
OpenTrials
Completed

NCT Number: NCT06925230

Arthroscopic Assisted Volar, Dorsal or Combined Capsulodesis in Scapholunate Ligament Injury.

The aim of this case series study is to test the efficacy of arthroscopic assisted volar, dorsal or combined scapholunate capsulodesis in the management of scapholunate ligament injuries.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ain Shams University

Cairo, Abbassia, 00000, Egypt

About this study

The aim of this case series study is to test the efficacy of arthroscopic assisted volar, dorsal or combined scapholunate capsulodesis in the management of scapholunate ligament injuries. All patients will be assessed preoperatively by careful history taking , full general and local examination and radiological evaluation using wrist plain X-rays (Standard PA, clenched-fist PA , PA in ulnar deviation , lateral projection in neutral ,flexion and extension ) and wrist Magnetic resonance imaging.an informed written consent was taken before any surgery. The procedure starts with a standard radiocarpal and then midcarpal arthroscopy. During the arthroscopic examination ,several factors are assessed, including the location of the SLIL injury (volar, membranous, dorsal, or complete), the condition of the cartilage, the reducibility of the carpus, and other associated pathologies like TFCC injury. Classification is done using Geissler Classification, Garcia Elias Classification and EWAS classification.Volar capsulodesis using Hayman Lui et al or Del Pinal et al method and/or dorsal capsulodesis using original Mathoulin technique or combined capsulodesis were done.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Sex: both sexes.
  • Age: above 18 years
  • Lesion: subacute or chronic scapholunate ligament injury
  • partial and complete SLIL tears

Exclusion criteria

  • Acute scapholunate ligament injury
  • irreducible carpal malalignment
  • posttraumatic arthritis
  • associated fractures that could affect the functional outcome

Treatment and study plan

arthroscopic assisted volar scapholunate capsulodesis

Procedure

arthroscopic assisted volar scapholunate capsulodesis using PDS 2.00 sutures

Other names: volar scapholunate capsuloligamentodesis

arthroscopic assisted dorsal scapholunate capsulodesis

Procedure

arthroscopic assisted dorsal scapholunate capsulodesis using PDS 2.00 sutures

arthroscopic assisted combined volar and dorsal scapholunate capsulodesis

Procedure

arthroscopic assisted combined volar and dorsal scapholunate capsulodesis using PDS 2.00 sutures

Primary outcomes

  1. wrist range of motion

    Time frame: preoperative and postoperative after 3months , 6months , 9months and 12months

    wrist range of motion degrees in flexion , extension, radial deviation and ulnar deviation.

Secondary outcomes

  1. scapholunate gap

    Time frame: preoperative and postoperative scapholunate gaps after 3months , 6months , 9months and 12months

    scapholunate gap in PA wrist plain Xray is the distance between middle of scaphoid and middle of lunate bones in PA wrist plain Xray in millimeters

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Arthroscopic Assisted Volar, Dorsal or Combined Capsulodesis in Scapholunate Ligament Injury

Acronym: case series

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Apr 13, 2025
Registry last updated
Apr 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.